# Bupropion in Helping Adults Stop Smoking

> **NCT00534001** · PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 95 (actual)

## Conditions studied

- Bladder Cancer
- Cervical Cancer
- Esophageal Cancer
- Gastric Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer
- Tobacco Use Disorder

## Interventions

- **DRUG:** bupropion hydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00534001
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-05
- **Final completion:** 2015-07
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534001, "Bupropion in Helping Adults Stop Smoking". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00534001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*